Mabaga, Madeleine G.
HRN: 13-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 750MG (VIAL)
06/08/2022
06/10/2022
IV
750mg
Q8H
S/P LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose
Overall appropriateness: No Wrong Dose